Eterna 2mg/ml Injection contains Ondansetron, a selective 5-HT3 receptor antagonist used primarily to prevent nausea and vomiting caused by chemotherapy, radiotherapy, and surgery. Each milliliter of the injection delivers 2mg of Ondansetron, which works by blocking the action of serotonin, a natural substance that may trigger nausea and vomiting. Eterna is administered intravenously or intramuscularly, allowing for rapid onset of action, making it effective in controlling acute emesis. It is commonly prescribed to patients undergoing cancer treatments, where it significantly improves quality of life by reducing the distressing symptoms of nausea and vomiting. The dosage and duration of treatment depend on the patient’s condition, age, and response to therapy, and it should be used under medical supervision. Eterna 2mg/ml Injection is generally well tolerated, with side effects such as headache, constipation, and dizziness being relatively uncommon and mild. It is contraindicated in patients with known hypersensitivity to Ondansetron or any component of the formulation. Careful consideration is advised in patients with liver impairment or cardiac conditions. Overall, Eterna 2mg/ml Injection is a valuable antiemetic agent that enhances patient comfort during challenging medical treatments.